Science for a Brighter Tomorrow

Overview

Adamis Pharmaceuticals

Founded in 2006 and headquartered in San Diego, California, Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) is an emerging pharmaceutical company combining specialty pharmaceuticals and biotechnology to provide innovative medicines for patients, physicians and healthcare organizations. With its unique business model within the healthcare industry, Adamis is focused on attaining profitability through a series of specialty pharmaceutical pipeline products that will seek approval through the shorter 505(b)(2) pathway before certain resources are applied to further the biotechnology pipeline products. With novel products and breakthrough science, ADMP is poised to become a leader in the biopharmaceutical industry. Adamis products are concentrated in multi-billion dollar therapeutic areas including:

  • Respiratory (asthma, COPD)
  • Allergy (anaphylaxis, allergic rhinitis)
  • Oncology (cancer)